Surface expression of RELT was observed at similar levels in cell lines representing lung cancer (H358) and breast cancer (MCF7 and 231) (Figure 1B), and it is therefore worth investigating if upregulated RELT can serve as the receptor for chemotherapy delivery systems in patients with breast cancer. Here, RELT is linked to breast carcinoma.